Pilot Study of the Efficacy and Safety of Sirolimus in the Treatment of Congenital Hyperinsulinism.

Trial Profile

Pilot Study of the Efficacy and Safety of Sirolimus in the Treatment of Congenital Hyperinsulinism.

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 18 Oct 2017

At a glance

  • Drugs Sirolimus (Primary)
  • Indications Hyperinsulinaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 19 Sep 2017 Planned End Date changed from 1 Jun 2017 to 1 Jun 2018.
    • 19 Sep 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2018.
    • 15 Sep 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top